Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02357251 · ClinicalTrials.gov registry record · NA

Enhanced Recovery After Surgery: A RCT of Perioperative Management of Gynecologic Patients

A NA study, sponsored by Case Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT02357251: Completed NA study, sponsored by Case Comprehensive Cancer Center.

NCT02357251 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02357251, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

This is a single-blinded randomized control trial comparing the current perioperative care of the investigators gynecologic oncology patients with a standardized perioperative "enhanced recovery" pathway. Adult patients undergoing laparotomy by one of the gynecologic oncology surgeons will be eligible to participate. The primary outcome will be length of hospitalization including any days of readmission in the 30 days post-operatively. Secondary outcomes will include 30-day readmission rate, complications, quality of recovery, and pain control.

Primary Outcome

Hospital days in first 30 days post-operatively (Length of stay of primary hospitalization plus any days of readmission)

Interventions

  • OTHER Enhanced recovery protocol

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2014-12-12
Est. Completion 2017-07-03
Phase NA
Case Comprehensive Cancer Center

407 total trials

What the finished NCT02357251 record still lists

NCT02357251 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Enhanced recovery protocol is the first listed.

NCT02357251 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02357251 about?

NCT02357251 is a clinical study titled "Enhanced Recovery After Surgery: A RCT of Perioperative Management of Gynecologic Patients". This is a single-blinded randomized control trial comparing the current perioperative care of the investigators gynecologic oncology patients with a standardized perioperative "enhanced recovery" pathway. Adult patients undergoing laparotomy by one of the gynecologic oncology surgeons will be eligib...

What is the current status of trial NCT02357251?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2014-12-12. Estimated completion is 2017-07-03.

What interventions are being tested in trial NCT02357251?

The interventions under investigation include: Enhanced recovery protocol (OTHER).

Who is sponsoring clinical trial NCT02357251?

This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02357251's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02357251, the US trial registry maintained by the National Library of Medicine. NCT02357251 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.